Asian Pacific asian A As Asi Asia BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 10 0 0 1 1 0
411 411 411 4 41 411 411 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
DOI:10.31557/APJCP.2020.21.2.411 DOI:10.31557/APJCP.2020.21.2.411 doi:10.31557/apjcp.2020.21.2.411 D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 :./.... 7 5 0 1 0 0 0
Design, One design, D De Des Desi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 10 0 1 0 0 0
Asian Pac asian A As Asi Asia BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,(),- 5 10 0 0 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Cancer is cancer C Ca Can Canc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
and accounts and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
infectious diseases infectious i in inf infe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,). 5 8 0 0 0 0 1
World Health world W Wo Wor Worl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 (), 3 7 0 0 0 0 1
cancer prevalence cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
cases of cases c ca cas case BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
2030 (El-Azab 2030 2 20 203 2030 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 0 (-.,;.,). 9 9 0 0 0 0 1
the increase the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
escalating costs, escalating e es esc esca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 10 0 0 0 0 1
unmet medical unmet u un unm unme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (,). 4 7 0 0 0 0 1
Therefore, the therefore, T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
agents to agents a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
urgently (Chakraborty urgently u ur urg urge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (,). 4 7 0 0 0 0 1
containing heterocyclic containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
pyridines core pyridines p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
discovery and discovery d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .(., 4 8 0 0 0 0 1
2016; Jabir 2016; 2 20 201 2016 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 ;.,) 4 9 0 0 0 0 1
core structure core c co cor core BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (, 2 9 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
Objective: The objective: O Ob Obj Obje BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 : 1 9 0 0 0 0 1
fused Pyrido[2,1-b] fused f fu fus fuse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 [,-].:, 7 9 0 0 0 0 1
one-pot synthesis one-pot o on one one- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ---[,-] 7 9 0 0 0 0 1
microwave synthesis microwave m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 . 1 9 0 0 0 0 1
against the against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ,-,-,-,-,.: 11 8 0 0 0 0 1
tested compounds, tested t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ,-(-----)-,,,---[,-]() 22 9 0 0 0 0 1
potent cytotoxicity potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -...., 6 9 0 0 0 0 1
respectively. Moreover, respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ., 2 9 0 0 0 0 1
of 2.70Â±0.18 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ....-,., 8 9 0 0 0 0 1
for compound for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ,/(/) 5 9 0 0 0 0 1
DAPI staining. dapi D DA DAP DAPI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 .,-. 4 9 0 0 0 0 1
flow cytometric flow f fl flo flow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 / 1 10 0 0 0 0 1
the cell the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 .,, 3 9 0 0 0 0 1
EGFR kinase egfr E EG EGF EGFR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 (:). 4 9 0 0 0 0 1
Conclusion: Overall, conclusion: C Co Con Conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 :,. 3 9 0 0 0 0 1
Keywords: One keywords: K Ke Key Keyw BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 :----. 6 10 0 0 0 0 1
RESEARCH ARTICLE research R RE RES RESE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 7 no 0 10 0 1 0 0 1
Design, One design, D De Des Desi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 8 0 1 0 0 1
Studies of studies S St Stu Stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 --[,-] 6 10 0 1 0 0 1
Apoptosis-Inducing Anticancer apoptosis-inducing A Ap Apo Apop BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 - 1 6 0 1 0 0 1
Raju Bathula raju R Ra Raj Raju BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 ,*,, 4 10 0 1 0 0 1
as metastatic as a as as as BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 -)( 3 9 0 0 0 0 1
Ahmad, 2017), ahmad, A Ah Ahm Ahma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 ,),(,) 6 9 0 0 0 0 1
(Helfrich et (helfrich ( (H (He (Hel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 (.,),(, 7 8 0 0 0 0 1
tumors) (Motyckova tumors) t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 )(,) 4 8 0 0 0 0 1
(IV, Hematological (iv, ( (I (IV (IV, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 (,).(.,) 8 9 0 0 0 0 1
structural moieties structural s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 9 0 0 0 0 1
biological activities biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 .,(.,), 7 10 0 0 0 0 1
analgesic (Samiksha analgesic a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 (,),( 5 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 .,),-(.,) 9 9 0 0 0 0 1
and anticonvulsant and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 .(.,) 5 9 0 0 0 0 1
Moreover, Pyridine moreover, M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 ,, 2 9 0 0 0 0 1
antiviral, anticancer, antiviral, a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 ,,- 3 10 0 0 0 0 1
properties (Kurumurthy properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 (.,;.,) 7 9 0 0 0 0 1
(Figure 1). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 (). 3 2 0 0 0 0 1
Pyrido [2,1-b]quinazoline pyrido P Py Pyr Pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 [,-]() 6 9 0 0 0 0 1
fused heterocyclic fused f fu fus fuse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 8 0 0 0 0 1
in many in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 8 , 1 8 0 0 0 0 1
interesting biological interesting i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 (.,; 4 9 0 0 0 0 1
Mikhalev et mikhalev M Mi Mik Mikh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 .,;.,; 6 8 0 0 0 0 1
and Gupta, and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,).[,-] 7 8 0 0 0 0 1
Editorial Process: editorial E Ed Edi Edit BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 :://:// 7 10 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 11 no 0 10 0 0 0 0 1
Centre for centre C Ce Cen Cent BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 ,,,,, 5 9 0 0 0 0 1
Pharmacy, Anurag pharmacy, P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 ,,,,,,,.*: 10 10 0 0 0 0 1
satlashobharani@gmail.com satlashobharani@gmail.com satlashobharani@gmail.com s sa sat satl BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 11 @. 2 2 0 0 0 0 1
Raju Bathula raju R Ra Raj Raju BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 1 1 0
Asian Pacific asian A As Asi Asia BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 1 1 1 0 0
412 412 412 4 41 412 412 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 1 0 0 0
been discovered been b be bee been BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 8 0 0 0 0 1
anti-inflammatory, analgesic, anti-inflammatory, a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -,,. 4 9 0 0 0 0 1
years fused years y ye yea year BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
attention because attention a at att atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 0 0 0 0 1
some of some s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [,-] 4 8 0 0 0 0 1
motifs as motifs m mo mot moti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,[',':,] 8 9 0 0 0 0 1
[1, 5-a] [1, [ [1 [1, [1, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 [,-]() 6 9 0 0 0 0 1
activity (Kumar activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (.,) 4 9 0 0 0 0 1
literature. Pyrazolo[3, literature. l li lit lite BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .[,-]() 7 9 0 0 0 0 1
known to known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 0 0 0 0 1
anti-inflammatory activities anti-inflammatory a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -(.,; 5 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .,)()., 7 9 0 0 0 0 1
known for known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
of aminopyrimidine, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
Pyrido [2,1-b]quinazoline pyrido P Py Pyr Pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 [,-] 4 8 0 0 0 0 1
(Yang et (yang ( (Y (Ya (Yan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (.,;.,)., 9 9 0 0 0 0 1
study focused study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
single molecule single s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [,-] 4 9 0 0 0 0 1
quinazoline to quinazoline q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
resulting moieties resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
by MTT by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
cell growth cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 0 0 0 0 1
clonogenic growth clonogenic c cl clo clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,- 2 9 0 0 0 0 1
apoptosis. apoptosis. apoptosis. a ap apo apop BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 1 0 0 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
Chemistry Chemistry chemistry C Ch Che Chem BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 1 1 1 0 0 1
A three a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 4 ,- 2 8 1 1 0 0 1
1H-Pyrido[2,1-b] Quinazoline 1h-pyrido[2,1-b] 1 1H 1H- 1H-P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 -[,-] 5 9 1 1 0 0 1
of 2-aminopyrimidines, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -, 2 9 1 1 0 0 1
and ketones and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
reflux or reflux r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
catalyst were catalyst c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 9 1 1 0 0 1
compounds were compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
and characterized and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,. 2 10 1 1 0 0 1
The physical the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
shown in shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 1 1 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 6 1 1 0 0 1
To assess to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 1 1 0 0 1
compounds in compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,,-, 4 7 1 1 0 0 1
HT-29, HCT-15, ht-29, H HT HT- HT-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -,-,-- 6 8 1 1 0 0 1
normal lung normal n no nor norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 3 3- 3-( 3-(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -(,---)-,- 10 8 1 1 0 0 1
bromide (MTT) bromide b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 8 1 1 0 0 1
disclosed that disclosed d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 1 1 0 0 1
assorted anticancer assorted a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 1 1 0 0 1
the closer the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 10 1 1 0 0 1
compound 4i compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
in all in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .., 3 9 1 1 0 0 1
in NCI-H460 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 - 1 8 1 1 0 0 1
at 5.53Â±0.49 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .., 3 7 1 1 0 0 1
has specificity has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 1 1 0 0 1
compared the compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 1 1 0 0 1
cell line cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -.. 3 8 1 1 0 0 1
ÂµM respectively Âµm Âµ ÂµM ÂµM ÂµM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ()., 4 8 1 1 0 0 1
found to found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 8 1 1 0 0 1
the cancer the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 8 1 1 0 0 1
remarkable cytotoxicity remarkable r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .. 2 8 1 1 0 0 1
against the against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -, 2 9 1 1 0 0 1
the compound the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 1 1 0 0 1
and selectivity and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .. 2 9 1 1 0 0 1
and 12.64Â±0.35 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ..-. 4 8 1 1 0 0 1
These results these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
hope in hope h ho hop hope BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
of novel of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 7 1 1 0 0 1
In vitro in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 10 no 0 6 1 1 0 0 1
The synthesized the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 8 1 1 0 0 1
for their for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 10 1 1 0 0 1
cell lines cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 . 1 9 1 1 0 0 1
(ÂµM) values (Âµm) ( (Âµ (ÂµM (ÂµM) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 ()( 3 8 1 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 . 1 10 1 1 0 0 1
Scheme 1. scheme S Sc Sch Sche BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 .--[,-] 7 10 1 1 0 0 1
Asian Pacific asian A As Asi Asia BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 1 1 1 0 0
DOI:10.31557/APJCP.2020.21.2.411 DOI:10.31557/APJCP.2020.21.2.411 doi:10.31557/apjcp.2020.21.2.411 D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 1 0 :./.... 7 5 1 1 0 0 0
Design, One design, D De Des Desi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 1 1 0 0 0
ÂµM in Âµm Âµ ÂµM ÂµM ÂµM BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 1 0 0 0 1
towards lung towards t to tow towa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
potential, and potential, p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 1 0 0 0 1
cells with cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ..,.. 5 9 1 0 0 0 1
HT-29 and ht-29 H HT HT- HT-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 --()., 6 10 1 0 0 0 1
compounds examined compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
growth inhibition, growth g gr gro grow BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,,, 3 10 1 0 0 0 1
growth of growth g gr gro grow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ) 1 8 1 0 0 0 1
listed in listed l li lis list BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 10 1 0 0 0 1
the compounds the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 8 1 0 0 0 1
inhibition against inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 10 1 0 0 0 1
series, from series, s se ser seri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ,, 2 9 1 0 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 8 1 0 0 0 1
inhibition with inhibition i in inh inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 .... 4 9 1 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 .)(,-) 6 9 1 0 0 0 1
fibroblasts HFL-1; fibroblasts f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 -;) 3 10 1 0 0 0 1
to normal to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -....().***.,**., 17 9 1 0 0 0 1
HFL-1 cell hfl-1 H HF HFL HFL- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 -. 2 1 1 0 0 0 1
Cell line cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 9 1 0 0 0 1
A549 a a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 6 1 0 0 0 1
NCI-H460 b nci-h460 N NC NCI NCI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 - 1 10 1 0 0 0 1
HT-29 c ht-29 H HT HT- HT-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 - 1 7 1 0 0 0 1
HCT-15 d hct-15 H HC HCT HCT- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 - 1 8 1 0 0 0 1
DU-145 e du-145 D DU DU- DU-1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 - 1 8 1 0 0 0 1
HFL-1 f hfl-1 H HF HFL HFL- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 - 1 7 1 0 0 0 1
4a 4a 4a 4 4a 4a 4a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 7 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 1 0 0 0 1
4b 4b 4b 4 4b 4b 4b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
4c 4c 4c 4 4c 4c 4c BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
4d 4d 4d 4 4d 4d 4d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
4e 4e 4e 4 4e 4e 4e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 no 0 2 0 0 0 0 1
43.08Â±2.43 43.08Â±2.43 43.08Â±2.43 4 43 43. 43.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
43.18Â±2.58 43.18Â±2.58 43.18Â±2.58 4 43 43. 43.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
39.48Â±1.40 39.48Â±1.40 39.48Â±1.40 3 39 39. 39.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
40.91Â±0.55 40.91Â±0.55 40.91Â±0.55 4 40 40. 40.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
23.25Â±0.25 23.25Â±0.25 23.25Â±0.25 2 23 23. 23.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
84.96Â±3.80 84.96Â±3.80 84.96Â±3.80 8 84 84. 84.9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
4f 4f 4f 4 4f 4f 4f BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 no 0 2 0 0 0 0 1
12.84Â±1.50 12.84Â±1.50 12.84Â±1.50 1 12 12. 12.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
12.64Â±0.35 12.64Â±0.35 12.64Â±0.35 1 12 12. 12.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
15.40Â±0.11 15.40Â±0.11 15.40Â±0.11 1 15 15. 15.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
19.26Â±1.16 19.26Â±1.16 19.26Â±1.16 1 19 19. 19.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
16.08Â±0.14 16.08Â±0.14 16.08Â±0.14 1 16 16. 16.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
15.23Â±0.30 15.23Â±0.30 15.23Â±0.30 1 15 15. 15.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .. 2 10 0 0 0 0 1
4g 4g 4g 4 4g 4g 4g BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 2 0 0 0 0 1
25.54Â±3.98 25.54Â±3.98 25.54Â±3.98 2 25 25. 25.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
41.51Â±1.27 41.51Â±1.27 41.51Â±1.27 4 41 41. 41.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
41.33Â±1.43 41.33Â±1.43 41.33Â±1.43 4 41 41. 41.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
28.59Â±1.96 28.59Â±1.96 28.59Â±1.96 2 28 28. 28.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
32.86Â±3.77 32.86Â±3.77 32.86Â±3.77 3 32 32. 32.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
63.09Â±1.79 63.09Â±1.79 63.09Â±1.79 6 63 63. 63.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
4h 4h 4h 4 4h 4h 4h BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 7 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 10 0 0 0 0 1
4i 4i 4i 4 4i 4i 4i BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 no 0 2 0 0 0 0 1
4.57Â±0.25 4.57Â±0.25 4.57Â±0.25 4 4. 4.5 4.57 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 9 0 0 0 0 1
5.53Â±0.49 5.53Â±0.49 5.53Â±0.49 5 5. 5.5 5.53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 9 0 0 0 0 1
11.57Â±0.04 11.57Â±0.04 11.57Â±0.04 1 11 11. 11.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
11.31Â±0.25 11.31Â±0.25 11.31Â±0.25 1 11 11. 11.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 10 0 0 0 0 1
9.15Â±0.09 9.15Â±0.09 9.15Â±0.09 9 9. 9.1 9.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 9 0 0 0 0 1
8.70Â±0.36 8.70Â±0.36 8.70Â±0.36 8 8. 8.7 8.70 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .. 2 9 0 0 0 0 1
4j 4j 4j 4 4j 4j 4j BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 no 0 2 0 0 0 0 1
8.98Â±0.32 8.98Â±0.32 8.98Â±0.32 8 8. 8.9 8.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .. 2 9 0 0 0 0 1
9.27Â±0.54 9.27Â±0.54 9.27Â±0.54 9 9. 9.2 9.27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .. 2 9 0 0 0 0 1
7.25Â±0.38 7.25Â±0.38 7.25Â±0.38 7 7. 7.2 7.25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .. 2 9 0 0 0 0 1
10.88Â±0.40 10.88Â±0.40 10.88Â±0.40 1 10 10. 10.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .. 2 10 0 0 0 0 1
12.57Â±0.23 12.57Â±0.23 12.57Â±0.23 1 12 12. 12.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .. 2 10 0 0 0 0 1
9.31Â±0.32 9.31Â±0.32 9.31Â±0.32 9 9. 9.3 9.31 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .. 2 9 0 0 0 0 1
Table 1. table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 .() 3 10 1 0 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 .). 3 9 1 1 0 0 1
treated with treated t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 .,,.. 5 10 1 1 0 0 1
a phase a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 8 ;)- 3 9 1 1 0 0 1
bromide (AO/EB) bromide b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (/). 4 9 1 1 0 0 1
normal structure normal n no nor norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 , 1 9 1 1 0 0 1
0.5, 1, 0.5, 0 0. 0.5 0.5, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .,,.,, 6 9 1 1 0 0 1
fragmented nuclei. fragmented f fr fra frag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 .. 2 7 1 1 0 0 1
a a a a a a a BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 11 no 0 10 0 0 0 0 1
A549, adenocarcinoma; a549, A A5 A54 A549 BLOCKSTART PAGEEND SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 ,;;;;;- 7 10 0 0 0 0 1
Raju Bathula raju R Ra Raj Raju BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 1 1 0 0
Asian Pacific asian A As Asi Asia BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 10 0 1 1 0 0
414 414 414 4 41 414 414 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 1 0 0 0
promising growth promising p pr pro prom BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
found to found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
cancer cells. cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
for mechanistic for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
growth inhibition growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 0 0 0 0 1
These encouraging these T Th The Thes BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
in further in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 1 . 1 10 0 0 0 0 1
Morphological observations morphological M Mo Mor Morp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
microscope microscope microscope m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 1 0 0 0 0 1
The induction the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
formation is formation f fo for form BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 - 1 10 0 0 0 0 1
Cell line cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 1 0 0 1
A549 a a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 no 0 6 0 1 0 0 1
NCI-H460 b nci-h460 N NC NCI NCI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 - 1 10 0 1 0 0 1
HT-29 c ht-29 H HT HT- HT-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 - 1 7 0 1 0 0 1
HCT-15 d hct-15 H HC HCT HCT- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 - 1 8 0 1 0 0 1
DU-145 e du-145 D DU DU- DU-1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 - 1 8 0 1 0 0 1
HFL-1 f hfl-1 H HF HFL HFL- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 - 1 7 0 1 0 0 1
4a 4a 4a 4 4a 4a 4a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 7 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
4b 4b 4b 4 4b 4b 4b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 7 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
4c 4c 4c 4 4c 4c 4c BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 7 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
4d 4d 4d 4 4d 4d 4d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 7 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
4e 4e 4e 4 4e 4e 4e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 no 0 2 1 1 0 0 1
29.53Â±0.79 29.53Â±0.79 29.53Â±0.79 2 29 29. 29.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 .. 2 10 1 1 0 0 1
20.83Â±1.82 20.83Â±1.82 20.83Â±1.82 2 20 20. 20.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 .. 2 10 1 1 0 0 1
15.75Â±0.97 15.75Â±0.97 15.75Â±0.97 1 15 15. 15.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 .. 2 10 1 1 0 0 1
23.44Â±0.20 23.44Â±0.20 23.44Â±0.20 2 23 23. 23.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 .. 2 10 1 1 0 0 1
17.7Â±0.13 17.7Â±0.13 17.7Â±0.13 1 17 17. 17.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 .. 2 9 1 1 0 0 1
68.64Â±3.20 68.64Â±3.20 68.64Â±3.20 6 68 68. 68.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 .. 2 10 1 1 0 0 1
4f 4f 4f 4 4f 4f 4f BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 no 0 2 1 1 0 0 1
8.64Â±0.40 8.64Â±0.40 8.64Â±0.40 8 8. 8.6 8.64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 9 1 1 0 0 1
9.62Â±0.41 9.62Â±0.41 9.62Â±0.41 9 9. 9.6 9.62 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 9 1 1 0 0 1
11.43Â±0.06 11.43Â±0.06 11.43Â±0.06 1 11 11. 11.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 1 0 0 1
12.94Â±0.73 12.94Â±0.73 12.94Â±0.73 1 12 12. 12.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 1 0 0 1
11.35Â±0.34 11.35Â±0.34 11.35Â±0.34 1 11 11. 11.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 1 0 0 1
11.63Â±0.17 11.63Â±0.17 11.63Â±0.17 1 11 11. 11.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 1 0 0 1
4g 4g 4g 4 4g 4g 4g BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 no 0 2 1 0 0 0 1
9.23Â±0.93 9.23Â±0.93 9.23Â±0.93 9 9. 9.2 9.23 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 9 1 0 0 0 1
17.48Â±2.05 17.48Â±2.05 17.48Â±2.05 1 17 17. 17.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 0 0 0 1
20.81Â±3.74 20.81Â±3.74 20.81Â±3.74 2 20 20. 20.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 0 0 0 1
10.03Â±0.97 10.03Â±0.97 10.03Â±0.97 1 10 10. 10.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 0 0 0 1
7.37Â±2.50 7.37Â±2.50 7.37Â±2.50 7 7. 7.3 7.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 9 1 0 0 0 1
41.69Â±0.98 41.69Â±0.98 41.69Â±0.98 4 41 41. 41.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .. 2 10 1 0 0 0 1
4h 4h 4h 4 4h 4h 4h BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 7 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 1 0 0 0 1
>30 >30 >30 > >3 >30 >30 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 10 1 0 0 0 1
4i 4i 4i 4 4i 4i 4i BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 3 1 0 0 0 1
2.70Â±0.18 2.70Â±0.18 2.70Â±0.18 2 2. 2.7 2.70 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
3.24Â±0.40 3.24Â±0.40 3.24Â±0.40 3 3. 3.2 3.24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
5.98Â±0.18 5.98Â±0.18 5.98Â±0.18 5 5. 5.9 5.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
6.27Â±0.19 6.27Â±0.19 6.27Â±0.19 6 6. 6.2 6.27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
9.64Â±0.37 9.64Â±0.37 9.64Â±0.37 9 9. 9.6 9.64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
4.54Â±0.59 4.54Â±0.59 4.54Â±0.59 4 4. 4.5 4.54 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
4j 4j 4j 4 4j 4j 4j BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 no 0 3 1 0 0 0 1
5.79Â±0.14 5.79Â±0.14 5.79Â±0.14 5 5. 5.7 5.79 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
7.10Â±0.19 7.10Â±0.19 7.10Â±0.19 7 7. 7.1 7.10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
4.40Â±0.20 4.40Â±0.20 4.40Â±0.20 4 4. 4.4 4.40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
7.81Â±0.65 7.81Â±0.65 7.81Â±0.65 7 7. 7.8 7.81 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
8.10Â±0.10 8.10Â±0.10 8.10Â±0.10 8 8. 8.1 8.10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
7.67Â±0.22 7.67Â±0.22 7.67Â±0.22 7 7. 7.6 7.67 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .. 2 10 1 0 0 0 1
Table 2. table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 .() 3 10 0 1 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 .). 3 9 1 0 0 0 1
compound 4i compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .,,.. 5 9 1 0 0 0 1
The treatment the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 9 1 0 0 0 1
changes such changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 ,;) 3 9 1 0 0 0 1
compound 4i compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 9 1 0 0 0 1
at 1, at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ,.., 4 10 1 0 0 0 1
fusion chemdoc fusion f fu fus fusi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .- 2 9 1 0 0 0 1
cancer cells. cancer c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .. 2 7 1 0 0 0 1
Compounds Compounds compounds C Co Com Comp BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 6 0 0 0 0 1
Human Human human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 4 0 0 0 0 1
intestinal intestinal intestinal i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 7 0 0 0 0 1
absorption (%) absorption a ab abs abso BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 () 2 10 0 0 0 0 1
in vitro in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 no 0 4 0 0 0 0 1
Caco-2 cell caco-2 C Ca Cac Caco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 - 1 5 0 0 0 0 1
permeability (nm/sec) permeability p pe per perm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (/) 3 10 0 0 0 0 1
in vitro in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 no 0 6 0 0 0 0 1
MDCK cell mdck M MD MDC MDCK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 7 0 0 0 0 1
permeability permeability permeability p pe per perm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
(nm/sec) (nm/sec) (nm/sec) ( (n (nm (nm/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (/) 3 6 0 0 0 0 1
in vitro in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 no 0 6 0 0 0 0 1
Plasma protein plasma P Pl Pla Plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
binding binding binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 5 0 0 0 0 1
(%) (%) (%) ( (% (%) (%) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 () 2 2 0 0 0 0 1
in vivo in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 - 1 7 0 0 0 0 1
brain barrier brain b br bra brai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 no 0 7 0 0 0 0 1
penetration penetration penetration p pe pen pene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 6 0 0 0 0 1
(C.brain/C.blood) (C.brain/C.blood) (c.brain/c.blood) ( (C (C. (C.b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (./.) 5 10 0 0 0 0 1
Skin Skin skin S Sk Ski Skin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 3 0 0 0 0 1
Permeability Permeability permeability P Pe Per Perm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
4a 4a 4a 4 4a 4a 4a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 4 0 0 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 10 0 0 0 0 1
47.55 47.55 47.55 4 47 47. 47.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 8 0 0 0 0 1
22.36 22.36 22.36 2 22 22. 22.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 8 0 0 0 0 1
90.03 90.03 90.03 9 90 90. 90.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 8 0 0 0 0 1
1.65 1.65 1.65 1 1. 1.6 1.65 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 7 0 0 0 0 1
-2.95 -2.95 -2.95 - -2 -2. -2.9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 -. 2 8 0 0 0 0 1
4b 4b 4b 4 4b 4b 4b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 10 0 0 0 0 1
54.46 54.46 54.46 5 54 54. 54.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
12.36 12.36 12.36 1 12 12. 12.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
99.22 99.22 99.22 9 99 99. 99.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
2.73 2.73 2.73 2 2. 2.7 2.73 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 7 0 0 0 0 1
-3.03 -3.03 -3.03 - -3 -3. -3.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -. 2 8 0 0 0 0 1
4c 4c 4c 4 4c 4c 4c BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 5 0 0 0 0 1
98.45 98.45 98.45 9 98 98. 98.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 10 0 0 0 0 1
1.68 1.68 1.68 1 1. 1.6 1.68 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
7.35 7.35 7.35 7 7. 7.3 7.35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
91.26 91.26 91.26 9 91 91. 91.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 10 0 0 0 0 1
0.19 0.19 0.19 0 0. 0.1 0.19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
-3.26 -3.26 -3.26 - -3 -3. -3.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -. 2 10 0 0 0 0 1
4d 4d 4d 4 4d 4d 4d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 4 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 10 0 1 0 0 1
57.96 57.96 57.96 5 57 57. 57.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 1 0 0 1
25.05 25.05 25.05 2 25 25. 25.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 1 0 0 1
92.43 92.43 92.43 9 92 92. 92.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 8 0 1 0 0 1
0.57 0.57 0.57 0 0. 0.5 0.57 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 . 1 7 0 1 0 0 1
-3.31 -3.31 -3.31 - -3 -3. -3.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -. 2 8 0 1 0 0 1
4e 4e 4e 4 4e 4e 4e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 4 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
35.84 35.84 35.84 3 35 35. 35.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
19.16 19.16 19.16 1 19 19. 19.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
89.60 89.60 89.60 8 89 89. 89.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
2.28 2.28 2.28 2 2. 2.2 2.28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 7 0 1 0 0 1
-2.93 -2.93 -2.93 - -2 -2. -2.9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -. 2 8 0 1 0 0 1
4f 4f 4f 4 4f 4f 4f BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 4 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
47.91 47.91 47.91 4 47 47. 47.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
8.35 8.35 8.35 8 8. 8.3 8.35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 7 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
3.68 3.68 3.68 3 3. 3.6 3.68 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 7 0 1 0 0 1
-3.07 -3.07 -3.07 - -3 -3. -3.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -. 2 8 0 1 0 0 1
4g 4g 4g 4 4g 4g 4g BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 4 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
55.03 55.03 55.03 5 55 55. 55.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
26.92 26.92 26.92 2 26 26. 26.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
2.53 2.53 2.53 2 2. 2.5 2.53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 7 0 1 0 0 1
-3.42 -3.42 -3.42 - -3 -3. -3.4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -. 2 8 0 1 0 0 1
4h 4h 4h 4 4h 4h 4h BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 4 0 1 0 0 1
97.60 97.60 97.60 9 97 97. 97.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
56.83 56.83 56.83 5 56 56. 56.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
220.12 220.12 220.12 2 22 220 220. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
88.73 88.73 88.73 8 88 88. 88.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
0.10 0.10 0.10 0 0. 0.1 0.10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 7 0 1 0 0 1
3.70 3.70 3.70 3 3. 3.7 3.70 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 7 0 1 0 0 1
4i 4i 4i 4 4i 4i 4i BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 no 0 4 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 10 0 1 0 0 1
32.34 32.34 32.34 3 32 32. 32.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 8 0 1 0 0 1
13.75 13.75 13.75 1 13 13. 13.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 8 0 1 0 0 1
100.00 100.00 100.00 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 10 0 1 0 0 1
2.17 2.17 2.17 2 2. 2.1 2.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 7 0 1 0 0 1
-2.41 -2.41 -2.41 - -2 -2. -2.4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 -. 2 8 0 1 0 0 1
4j 4j 4j 4 4j 4j 4j BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 no 0 5 0 1 0 0 1
94.39 94.39 94.39 9 94 94. 94.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 10 0 1 0 0 1
27.22 27.22 27.22 2 27 27. 27.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 10 0 1 0 0 1
17.45 17.45 17.45 1 17 17. 17.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 10 0 1 0 0 1
93.52 93.52 93.52 9 93 93. 93.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 10 0 1 0 0 1
9.38 9.38 9.38 9 9. 9.3 9.38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 . 1 8 0 1 0 0 1
-3.59 -3.59 -3.59 - -3 -3. -3.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 -. 2 10 0 1 0 0 1
Table 3. table T Ta Tab Tabl BLOCKSTART PAGEEND SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 . 1 10 0 0 0 0 1
Asian Pacific asian A As Asi Asia BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 10 0 0 1 0 0
DOI:10.31557/APJCP.2020.21.2.411 DOI:10.31557/APJCP.2020.21.2.411 doi:10.31557/apjcp.2020.21.2.411 D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 0 :./.... 7 5 1 1 0 0 0
Design, One design, D De Des Desi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 10 1 1 0 0 0
therapeutics (Ward therapeutics t th the ther BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (.,). 5 9 0 0 0 0 1
treatment with treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
the compound the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
captured in captured c ca cap capt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
the shrinkage the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
of dead of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
these characteristic these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
control cells control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
in Figure in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 . 1 2 0 0 0 0 1
Acridine orange/ethidium acridine A Ac Acr Acri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 /(/) 4 8 0 0 0 0 1
Acridine orange/ethidium acridine A Ac Acr Acri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 /(/) 4 8 0 0 0 0 1
assay was assay a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 9 0 0 0 0 1
and necrotic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 . 1 8 0 0 0 0 1
membrane and membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 9 0 0 0 0 1
stain the stain s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 10 0 0 0 0 1
and stain and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 . 1 9 0 0 0 0 1
with no with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 9 0 0 0 0 1
cells also cells c ce cel cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (.,). 5 9 0 0 0 0 1
can be can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 - 1 9 0 0 0 0 1
exhibited normal exhibited e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 0 0 0 0 1
Whereas, the whereas, W Wh Whe Wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 9 0 0 0 0 1
clearly induced clearly c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
as cell as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ,, 2 9 0 0 0 0 1
blebbing and blebbing b bl ble bleb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 , 1 9 0 0 0 0 1
the compound the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 8 0 0 0 0 1
cancer cells. cancer c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 2 0 0 0 0 1
DAPI staining dapi D DA DAP DAPI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 2 0 0 0 0 1
Apoptosis can apoptosis A Ap Apo Apop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
pronounced change pronounced p pr pro pron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 0 0 0 1
staining the staining s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
nucleus. nucleus. nucleus. n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 1 0 0 0 0 1
A549 cells a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
chromatin condensation, chromatin c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,, 2 9 0 0 0 0 1
shoe shaped shoe s sh sho shoe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
are clear are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 .). 3 9 1 1 0 0 1
of compound of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .. 2 9 1 1 0 0 1
J-aggregates in j-aggregates J J- J-a J-ag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 -, 2 9 1 1 0 0 1
of J-monomers; of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -;. 3 9 1 1 0 0 1
and treated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .,,.., 6 9 1 1 0 0 1
stained with stained s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 9 1 1 0 0 1
of cells of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,/,,/., 7 9 1 1 0 0 1
were acquired were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .)/ 3 9 1 1 0 0 1
PI staining. pi P PI PI PI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 .. 2 9 1 1 0 0 1
incubated for incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 -/-. 4 9 1 1 0 0 1
or necrosis or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,. 2 9 1 1 0 0 1
of cells of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -/. 3 9 1 1 0 0 1
left quadrant left l le lef left BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (-;-/):;(-;-/-):; 17 10 1 1 0 0 1
(Q3-LR; AV+/PI-): (q3-lr; ( (Q (Q3 (Q3- BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 (-;/-):(-;/):. 14 8 1 1 0 0 1
Raju Bathula raju R Ra Raj Raju BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 1 1 1 0 0
Asian Pacific asian A As Asi Asia BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 10 0 0 1 0 0
416 416 416 4 41 416 416 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 0
in the in i in in in BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 . 1 10 1 1 0 0 1
Effect of effect E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
Clonogenic assay clonogenic C Cl Clo Clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 2 0 0 0 0 1
The assay the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 "" 2 9 0 0 0 0 1
division by division d di div divi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
of colony of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
exponentially growing exponentially e ex exp expo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 0 0 0 0 1
cells per cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 0 0 0 0 1
different concentrations different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,.), 5 9 0 0 0 0 1
formation was formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 '., 3 8 0 0 0 0 1
formed colonies formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (. 2 8 0 0 0 0 1
v/v), stained v/v), v v/ v/v v/v) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 /),(./). 8 10 0 0 0 0 1
clearly retained clearly c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
manner. Reductions manner. m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 0 0 0 0 1
observed as observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ., 2 8 0 0 0 0 1
denote the denote d de den deno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
potential of potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 0 0 0 0 1
counted by counted c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
software and software s so sof soft BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
colony forming colony c co col colo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 4 0 0 0 0 1
Flow-cytometry analysis flow-cytometry F Fl Flo Flow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 - 1 4 0 0 0 0 1
Effect of effect E Ef Eff Effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 8 0 0 0 0 1
depolarization depolarization depolarization d de dep depo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 no 0 2 0 0 0 0 1
The fluorescent the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 - 1 9 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ., 2 9 0 0 0 0 1
there is there t th the ther BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 -. 2 10 0 0 0 0 1
The mitochondria the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
the intrinsic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
triggers, as triggers, t tr tri trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 , 1 10 0 0 0 0 1
stress, which stress, s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ,, 2 9 0 0 0 0 1
generate reactive generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ()( 3 8 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 .,)., 5 9 0 0 0 0 1
4i on 4i 4 4i 4i 4i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ,. 2 9 0 0 0 0 1
treatment with treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
the ÎÎ¨ the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
5A. The 5a. 5 5A 5A. 5A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 . 1 9 0 0 0 0 1
dose-dependently leading dose-dependently d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 - 1 9 0 0 0 0 1
transport. transport. transport. t tr tra tran BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 . 1 1 0 0 0 0 1
Effect of effect E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
From the from F Fr Fro From BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 0 0 0 1
lung cancer lung l lu lun lung BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ., 2 9 0 0 0 0 1
reveal whether reveal r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 0 0 0 1
arrest, cell arrest, a ar arr arre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 0 0 0 1
was parallel was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 0 0 0 1
(Å»uryÅ et (Å¼uryÅ ( (Å» (Å»u (Å»ur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (.,). 5 9 0 0 0 0 1
4i at 4i 4 4i 4i 4i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ., 2 9 0 0 0 0 1
and then and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 0 0 0 1
and analyzed and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
Figure 5A figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 10 0 0 0 0 1
showed 63.53% showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ./, 3 9 0 0 0 0 1
4i treatment 4i 4 4i 4i 4i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 / 1 9 0 0 0 0 1
population from population p po pop popu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .. 2 8 0 0 0 0 1
increased with increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,/ 2 9 0 0 0 0 1
arrest of arrest a ar arr arre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 / 1 9 0 0 0 0 1
prominent at prominent p pr pro prom BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .. 2 7 0 0 0 0 1
Annexin V annexin A An Ann Anne BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 6 1 1 0 0 1
To determine to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 8 1 1 0 0 1
4i treatment 4i 4 4i 4i 4i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 no 0 10 1 1 0 0 1
cell death, cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,-/ 3 8 1 1 0 0 1
performed. As performed. p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 .-, 3 8 1 1 0 0 1
fundamentally exhibited fundamentally f fu fun fund BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 , 1 9 1 1 0 0 1
population of population p po pop popu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 . 1 9 1 1 0 0 1
(control) to (control) ( (c (co (con BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 ()... 5 9 1 1 0 0 1
concentration evidenced concentration c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 . 1 9 1 1 0 0 1
Molecular Docking molecular M Mo Mol Mole BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 3 0 0 0 0 1
The docking the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 7 0 0 0 0 1
kinase was kinase k ki kin kina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 no 0 9 0 0 0 0 1
EGFR kinase. egfr E EG EGF EGFR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 . 1 9 0 0 0 0 1
MOE software moe M MO MOE MOE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 4 8 no 0 9 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (:). 4 9 0 0 0 0 1
docking calculations docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 8 0 0 0 0 1
were predicted. were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 . 1 9 0 0 0 0 1
4i, 4j 4i, 4 4i 4i, 4i, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 ,,, 3 10 0 0 0 0 1
were -17.47, were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -.,-.-./, 9 9 0 0 0 0 1
Table S2; table T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 ; 1 1 0 0 0 0 1
The docking the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 7 0 0 0 0 1
4i revealed 4i 4 4i 4i 4i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 no 0 9 0 0 0 0 1
corresponding ring corresponding c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 9 0 0 0 0 1
surrounding amino surrounding s su sur surr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 .-- 3 9 0 0 0 0 1
nucleus of nucleus n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 8 0 0 0 0 1
pi-H interaction pi-h p pi pi- pi-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 -.. 3 10 0 0 0 0 1
with energies with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -.-./. 6 9 0 0 0 0 1
compound 4i compound c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 8 0 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 . 1 9 1 1 0 0 1
the EGFR the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 8 1 1 0 0 1
Ligand; 3D ligand; L Li Lig Liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 ; 1 9 1 1 0 0 1
the EGFR the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 -: 2 9 1 1 0 0 1
3D and 3d 3 3D 3D 3D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 no 0 9 1 1 0 0 1
kinase with kinase k ki kin kina BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 -. 2 10 1 1 0 0 1
Asian Pacific asian A As Asi Asia BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 10 0 0 1 0 0
DOI:10.31557/APJCP.2020.21.2.411 DOI:10.31557/APJCP.2020.21.2.411 doi:10.31557/apjcp.2020.21.2.411 D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 :./.... 7 5 0 0 0 0 0
Design, One design, D De Des Desi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 10 0 0 0 0 0
Phe 699, phe P Ph Phe Phe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,. 3 6 0 0 0 0 1
The indole the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
binding mode binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
catalytic loop catalytic c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 4 0 0 0 0 1
In contrast, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 0 ,, 2 8 0 0 0 0 1
where the where w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 8 0 0 0 0 1
nucleus with nucleus n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -./.- 5 9 0 0 0 0 1
with Lys with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -./. 4 8 0 0 0 0 1
compound 4j compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
with Phe with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,,. 3 8 0 0 0 0 1
score for score s sc sco scor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
kinase was kinase k ki kin kina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -.,-.-.. 8 9 0 0 0 0 1
It is it I It It It BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 0 0 0 1
used to used u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
anticancer activity anticancer a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 7 0 0 0 0 1
ADME predictions adme A AD ADM ADME BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 2 no 0 2 0 1 0 0 1
The major the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 7 0 1 0 0 1
absorption, distribution, absorption, a ab abs abso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ,,. 3 9 0 1 0 0 1
in silico in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 -[,-] 5 10 0 1 0 0 1
quinazoline (4) quinazoline q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 () 2 8 0 1 0 0 1
results. Among results. r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 . 1 9 0 1 0 0 1
good intestinal good g go goo good BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 . 1 9 0 1 0 0 1
shown moderate shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 - 1 9 0 1 0 0 1
except 4c except e ex exc exce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
to moderate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
4h showed 4h 4 4h 4h 4h BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 .. 2 8 0 1 0 0 1
In vivo in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 2 - 1 9 0 1 0 0 1
that compound that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 8 0 1 0 0 1
4c, 4d, 4c, 4 4c 4c, 4c, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ,,. 3 9 0 1 0 0 1
All compounds all A Al All All BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 8 0 1 0 0 1
the value the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
also showed also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 . 1 9 0 1 0 0 1
predicted ADME predicted p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
in the in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 . 1 2 0 1 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 10 0 1 0 0 1
In conclusion, in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 3 ,- 2 8 0 1 0 0 1
[2,1-b]quinazoline (4) [2,1-b]quinazoline [ [2 [2, [2,1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 [,-]() 6 8 0 1 0 0 1
2-aminopyrimidines, substituted 2-aminopyrimidines, 2 2- 2-a 2-am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -, 2 8 0 1 0 0 1
and ketones and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 8 0 1 0 0 1
pot the pot p po pot pot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 [,-] 4 9 0 1 0 0 1
quinazoline (4) quinazoline q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 () 2 8 0 1 0 0 1
simple method simple s si sim simp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 . 1 8 0 1 0 0 1
The synthesized the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 8 0 1 0 0 1
cytotoxicity by cytotoxicity c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 no 0 8 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ,-,-,-, 7 8 0 1 0 0 1
DU-145 cancer du-145 D DU DU- DU-1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -- 2 7 0 1 0 0 1
fibroblasts cell fibroblasts f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ., 2 8 0 1 0 0 1
11-(1-benzyl-1H-indol-3-y1)-2, 3, 11-(1-benzyl-1h-indol-3-y1)-2, 1 11 11- 11-( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -(-----)-,,,--- 15 9 0 1 0 0 1
pyrido [2,1-b] pyrido p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 [,-]() 6 10 0 1 0 0 1
in A549 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 - 1 9 0 1 0 0 1
values 4.57Â±0.25 values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ....,. 6 8 0 1 0 0 1
induction of induction i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 8 0 1 0 0 1
changes of changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 no 0 9 0 1 0 0 1
microscopically shrinkage microscopically m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 1 0 0 1
of dead of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ./ 2 9 0 1 0 0 1
staining studies staining s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 1 0 0 1
dependently clearly dependently d de dep depe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 1 0 0 1
changes such changes c ch cha chan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 6 ,, 2 9 0 0 0 0 1
membrane blebbing membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 8 0 0 0 0 1
indicating that indicating i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
A549 lung a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 . 1 8 0 0 0 0 1
inhibited by inhibited i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
manner. Furthermore, manner. m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ., 2 9 0 0 0 0 1
using compound using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
manner gave manner m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 6 ,) 2 9 0 0 0 0 1
were arrested were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 /.) 3 10 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .) 2 9 0 0 0 0 1
V-FITC/PI flow v-fitc/pi V V- V-F V-FI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 -/ 2 8 0 0 0 0 1
apoptosis. The apoptosis. a ap apo apop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 . 1 9 0 0 0 0 1
results indicated results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 6 no 0 9 0 0 0 0 1
interactions strongly interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 . 1 9 0 0 0 0 1
Overall, these overall, O Ov Ove Over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 10 0 0 0 0 1
would be would w wo wou woul BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 '. 2 8 0 0 0 0 1
Acknowledgment Acknowledgment acknowledgment A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 2 0 0 0 0 1
The authors the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 ,,, 3 9 0 0 0 0 1
for providing for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 10 0 0 0 0 1
UGC for ugc U UG UGC UGC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 . 1 4 0 0 0 0 1
Experimental Experimental experimental E Ex Exp Expe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 2 0 0 0 0 1
Chemistry Chemistry chemistry C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 1 0 0 0 0 1
All chemicals all A Al All All BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 9 0 0 0 0 1
Lancaster (Alfa lancaster L La Lan Lanc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 8 (,, 3 9 0 0 0 0 1
Hill, MA, hill, H Hi Hil Hill BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 ,,),..(, 8 8 0 0 0 0 1
India) and india) I In Ind Indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 ). 2 8 0 0 0 0 1
Reactions were reactions R Re Rea Reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 10 0 0 0 0 1
containing 60 containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -, 2 9 0 0 0 0 1
by UV by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 10 0 0 0 0 1
were determined were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 9 0 0 0 0 1
instruments of instruments i in ins inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 9 0 0 0 0 1
parts per parts p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ( 1 3 0 0 0 0 1
in ppm) in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 8 ) 1 5 0 0 0 0 1
TMS and tms T TM TMS TMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 . 1 9 0 0 0 0 1
spectroscopic data spectroscopic s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 , 1 9 0 0 0 0 1
protons. ESI protons. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 9 0 0 0 0 1
Quattro LC quattro Q Qu Qua Quat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 no 0 9 0 0 0 0 1
3.98 kV 3.98 3 3. 3.9 3.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .. 2 8 0 0 0 0 1
Melting points melting M Me Mel Melt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 9 0 0 0 0 1
melting point melting m me mel melt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 4 0 0 0 0 1
General procedure general G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 2 0 0 0 0 1
Preparation of preparation P Pr Pre Prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 10 [,-]() 6 7 0 0 0 0 1
A One-pot a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 6 10 - 1 6 0 0 0 0 1
employed for employed e em emp empl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (), 3 9 0 0 0 0 1
2-aminopyridine (1, 2-aminopyridine 2 2- 2-a 2-am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 -(,.),(,.) 10 8 0 0 0 0 1
and ketones and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (.) 3 9 0 0 0 0 1
of CF of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 9 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 10 0 0 0 0 1
by conventional by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 8 0 0 0 0 1
irradiation, the irradiation, i ir irr irra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 , 1 9 0 0 0 0 1
the TLC. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 . 1 8 0 0 0 0 1
rotavaccum pressure. rotavaccum r ro rot rota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 . 1 9 0 0 0 0 1
with ethyl with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 , 1 8 0 0 0 0 1
with sodium with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 9 0 0 0 0 1
compound later compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 8 0 0 0 0 1
by using by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (:) 3 9 0 0 0 0 1
to afford to t to to to BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 . 1 5 0 0 0 0 1
Î´ Î´ Î´ Î´ Î´ Î´ Î´ BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
Raju Bathula raju R Ra Raj Raju BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 1 1 0 0
Asian Pacific asian A As Asi Asia BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 10 0 0 1 0 0
418 418 418 4 41 418 418 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 0 0 0 0
Spectral data spectral S Sp Spe Spec BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 2 0 1 0 0 1
11-Phenyl-2, 3, 11-phenyl-2, 1 11 11- 11-P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 --,,,---[,-] 12 8 0 1 0 0 1
quinazoline (4a) quinazoline q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 () 2 2 0 1 0 0 1
m.p: 154-156 m.p: m m. m.p m.p: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .:-;:.-.(,),. 13 8 0 1 0 0 1
(t, 1H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (,,.),.-.(,),.(,,.), 20 10 0 1 0 0 1
5.37 (s, 5.37 5 5. 5.3 5.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(,),.-.(,),.-.(,); 19 9 0 1 0 0 1
NMR: Î´ nmr: N NM NMR NMR: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 :.,.,.,.,.,.,., 15 9 0 1 0 0 1
126.8, 123.6, 126.8, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.,.,.,.,.,.,.; 18 9 0 1 0 0 1
MS: m/z ms: M MS MS: MS: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 :/.[]. 6 4 0 1 0 0 1
11-(4-Chlorophenyl)-2, 3, 11-(4-chlorophenyl)-2, 1 11 11- 11-( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 -(-)-,,,---[, 13 9 0 0 0 0 1
1-b] quinazoline 1-b] 1 1- 1-b 1-b] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 -]() 4 3 0 0 0 0 1
mp: 88-93 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 :-;:.-.(,),.(, 14 9 0 0 0 0 1
1H, J 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 ,.),.(,),.-.(,),.-. 19 9 0 0 0 0 1
(m, 6H); (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 (,);:.,.,.,.,., 15 9 0 0 0 0 1
133.0, 129.4, 133.0, 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .,.,.,.,.,.,.,.,., 18 10 0 0 0 0 1
23.0, 22.6; 23.0, 2 23 23. 23.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .,.;:/.[]. 10 6 0 0 0 0 1
11-(4-Nitrophenyl)-2, 3, 11-(4-nitrophenyl)-2, 1 11 11- 11-( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 -(-)-,,,---[,-] 15 9 0 0 0 0 1
quinazoline (4c) quinazoline q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 () 2 2 0 0 0 0 1
mp: 150-151 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 :-;:.-.(,), 11 7 0 0 0 0 1
7.54-7.45 (m, 7.54-7.45 7 7. 7.5 7.54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .-.(,),.-.(,),.(,, 18 8 0 0 0 0 1
6.3), 6.46 6.3), 6 6. 6.3 6.3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .),.(,,.),.(,),.-.(,), 22 10 0 0 0 0 1
1.91-1.61 (m, 1.91-1.61 1 1. 1.9 1.91 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .-.(,);:/.[]. 13 7 0 0 0 0 1
11-(4-Methoxyphenyl)-2, 3, 11-(4-methoxyphenyl)-2, 1 11 11- 11-( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 -(-)-,,,--- 11 7 0 0 0 0 1
pyrido[2,1-b]quinazoline (4d) pyrido[2,1-b]quinazoline p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 [,-]() 6 5 0 0 0 0 1
mp: 88-89 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 :-;:.-.(,),.- 13 8 0 0 0 0 1
6.84 (m, 6.84 6 6. 6.8 6.84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .(,),.-.(,),.(,,.), 19 9 0 0 0 0 1
5.32 (s, 5.32 5 5. 5.3 5.32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .(,),.(,),.-.(,),.-. 20 9 0 0 0 0 1
(m, 6H); (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 (,);:.,.,.,.,., 15 9 0 0 0 0 1
133.4, 128.3,123.5, 133.4, 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .,.,.,.,.,.,.,.,., 18 10 0 0 0 0 1
26.7, 23.2, 26.7, 2 26 26. 26.7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .,.,.;:/.[]. 12 6 0 0 0 0 1
(p-Tolyl)-2, 3, (p-tolyl)-2, ( (p (p- (p-T BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 (-)-,,,---[,-] 14 8 0 0 0 0 1
quinazoline (4e) quinazoline q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 () 2 2 0 0 0 0 1
mp: 125-126 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 :-;:.-.(,),. 12 8 0 0 0 0 1
(t, 1H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 (,,.),.-.(,),.(,,.), 20 10 0 0 0 0 1
5.32 (s, 5.32 5 5. 5.3 5.32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 .(,),.-.(,),.-.(,); 19 9 0 0 0 0 1
NMR: Î´ nmr: N NM NMR NMR: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 :.,.,.,.,.,.,., 15 9 0 0 0 0 1
126.9, 123.5, 126.9, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 .,.,.,.,.,.,.,.,., 18 9 0 0 0 0 1
21.2; MS: 21.2; 2 21 21. 21.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 .;:/.[]. 8 5 0 0 0 0 1
8-Chloro-11-(4-chlorophenyl)-2, 3, 8-chloro-11-(4-chlorophenyl)-2, 8 8- 8-C 8-Ch BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ---(-)-,,,--- 13 9 0 0 0 0 1
pyrido [2, pyrido p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 [,-]() 6 5 0 0 0 0 1
mp: 131-132 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 :-;:.-.(,), 11 7 0 0 0 0 1
7.27-7.22 (m, 7.27-7.22 7 7. 7.2 7.27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .-.(,),.-.(,),.(,),. 20 9 0 0 0 0 1
(d, 1H, (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (,,.),.(,),.-.(,),.-. 21 10 0 0 0 0 1
(m, 6H); (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (,);:.,.,.,.,., 15 9 0 0 0 0 1
132.5, 129.4, 132.5, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .,.,.,.,.,.,.,.,., 18 9 0 0 0 0 1
22.9, 22.5; 22.9, 2 22 22. 22.9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .,.;:/.[]. 10 5 0 0 0 0 1
8-chloro-11-(4-fluorophenyl)-2,3,4,11-tetrahydro-1H- 8-chloro-11-(4-fluorophenyl)-2,3,4,11-tetrahydro-1H- 8-chloro-11-(4-fluorophenyl)-2,3,4,11-tetrahydro-1h- 8 8- 8-c 8-ch BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ---(-)-,,,--- 13 8 0 0 0 0 1
pyrido[2,1-b]quinazoline (4g) pyrido[2,1-b]quinazoline p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 [,-]() 6 5 0 0 0 0 1
mp: 88-93 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :-;:.-.(,),.(, 14 9 0 0 0 0 1
1H, J 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ,.),.(,),.-.(,),.-. 19 9 0 0 0 0 1
(m, 6H); (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,);:.,.,.,.,., 15 9 0 0 0 0 1
133.0, 129.4, 133.0, 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,.,., 18 10 0 0 0 0 1
23.0, 22.6; 23.0, 2 23 23. 23.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.;:/.[]. 10 6 0 0 0 0 1
11-(4-trimethoxyphenyl)-2, 3, 11-(4-trimethoxyphenyl)-2, 1 11 11- 11-( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 -(-)-,,,--- 11 8 0 1 0 0 1
pyrido[2,1-b] quinazoline pyrido[2,1-b] p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 [,-]() 6 5 0 1 0 0 1
mp: 89-92 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 :-;:.-.(,),.- 13 8 0 1 0 0 1
6.85 (m, 6.85 6 6. 6.8 6.85 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .(,),.-.(,),.(,),.(, 20 9 0 1 0 0 1
1H, J 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 ,.),.(,),.-.(,),.-. 19 9 0 1 0 0 1
(m, 6H); (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 (,);:.,.,.,.,., 15 9 0 1 0 0 1
132.5, 127.5, 132.5, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .,.,.,.,.,.,.,.,., 18 10 0 1 0 0 1
27.0, 24.0, 27.0, 2 27 27. 27.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 .,.,.;:/.[]. 12 7 0 1 0 0 1
11-(1-benzyl-1H-indol-3-yl)-2, 3, 11-(1-benzyl-1h-indol-3-yl)-2, 1 11 11- 11-( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 -(-----)-,,,--- 15 9 0 0 0 0 1
pyrido [2, pyrido p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 [,-]() 6 5 0 0 0 0 1
mp: 185-186 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 :-;:.-.(,),.- 13 8 0 0 0 0 1
7.35 (m, 7.35 7 7. 7.3 7.35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .(,),.-.(,),.(,),.(, 20 9 0 0 0 0 1
dd, J dd, d dd dd, dd, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 ,.,.),.(,,.),.-. 16 9 0 0 0 0 1
(s, 2H), (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 (,),.-.(,),.(,),.-. 19 9 0 0 0 0 1
(m,4H). 13 (m,4h). ( (m (m, (m,4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 (,).:.,.,.,.,., 15 9 0 0 0 0 1
132.5, 129.4, 132.5, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .,.,.,.,.,.,.,.,., 18 10 0 0 0 0 1
22.9, 22.5; 22.9, 2 22 22. 22.9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .,.;:/.[]. 10 6 0 0 0 0 1
11-(1H-indol-3-yl)-2, 3, 11-(1h-indol-3-yl)-2, 1 11 11- 11-( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 -(---)-,,,---[,- 16 9 0 0 0 0 1
b]quinazoline (4j) b]quinazoline b b] b]q b]qu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 ]() 3 3 0 0 0 0 1
mp: 180-182 mp: m mp mp: mp: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 :-;:.-.(,), 11 7 0 0 0 0 1
7.27-7.22 (m, 7.27-7.22 7 7. 7.2 7.27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .-.(,),.-.(,),.(,),. 20 9 0 0 0 0 1
(d, 1H, (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 (,,.),.-.(,),.-.(,); 20 9 0 0 0 0 1
13 C 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 8 :.,.,.,.,.,., 13 8 0 0 0 0 1
129.4, 128.3, 129.4, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .,.,.,.,.,.,.,.,., 18 10 0 0 0 0 1
22.5; MS: 22.5; 2 22 22. 22.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .;:/.[]. 8 5 0 0 0 0 1
Biological Activity biological B Bi Bio Biol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 3 0 0 0 0 1
Materials and materials M Ma Mat Mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 3 0 0 0 0 1
Cell culture cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 2 0 0 0 0 1
Various cancer various V Va Var Vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 9 0 0 0 0 1
activity of activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 .( 2 9 0 0 0 0 1
and NCI-H460), and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -),(--), 8 8 0 0 0 0 1
(DU-145) cancer (du-145) ( (D (DU (DU- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 (-)- 4 9 0 0 0 0 1
while normal while w wh whi whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 (-) 3 9 0 0 0 0 1
maintained in maintained m ma mai main BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 - 1 8 0 0 0 0 1
fetal bovine fetal f fe fet feta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 ()- 3 10 0 0 0 0 1
solution (Sigma). solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 (). 3 9 0 0 0 0 1
98% relative 98% 9 98 98% 98% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .- 2 10 0 0 0 0 1
of confluency of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ,- 2 9 0 0 0 0 1
0.25% trypsin/1 0.25% 0 0. 0.2 0.25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ./. 3 9 0 0 0 0 1
The compounds the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 9 0 0 0 0 1
(1 %) (1 ( (1 (1 (1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 (). 3 9 0 0 0 0 1
dilutions were dilutions d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 9 0 0 0 0 1
to obtain to t to to to BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 6 0 0 0 0 1
Cytotoxicity assay cytotoxicity C Cy Cyt Cyto BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 no 0 2 0 0 0 0 1
MTT assay mtt M MT MTT MTT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 no 0 6 0 0 0 0 1
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl ( (3 (3- (3-( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 11 (-(,---)-,- 11 8 0 0 0 0 1
bromide) by bromide) b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 ) 1 7 0 0 0 0 1
enzyme to enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 8 0 0 0 0 1
of MTT of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 , 1 8 0 0 0 0 1
level of level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 10 0 0 0 0 1
(Pordeli et (pordeli ( (P (Po (Por BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 (.,).,- 7 9 0 0 0 0 1
plates at plates p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 ,, 2 9 0 0 0 0 1
Âµl of Âµl Âµ Âµl Âµl Âµl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 . 1 8 0 0 0 0 1
Then the then T Th The Then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 8 0 0 0 0 1
After the after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 ,(./) 5 7 0 0 0 0 1
added and added a ad add adde BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 8 0 0 0 0 1
Asian Pacific asian A As Asi Asia BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 10 0 0 1 0 0
DOI:10.31557/APJCP.2020.21.2.411 DOI:10.31557/APJCP.2020.21.2.411 doi:10.31557/apjcp.2020.21.2.411 D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 :./.... 7 5 0 1 0 0 0
Design, One design, D De Des Desi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 10 0 1 0 0 0
was aspirated was w wa was was BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
dissolved by dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
at 37 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 9 0 1 0 0 1
by using by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 0 1 0 0 1
(Spectra Max, (spectra ( (S (Sp (Spe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,,) 4 9 0 1 0 0 1
wavelength(Nekkanti et wavelength(nekkanti w wa wav wave BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (.,). 5 6 0 1 0 0 1
Cell Growth cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 4 0 0 0 0 1
Briefly, the briefly, B Br Bri Brie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ,- 2 8 0 0 0 0 1
in 100 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 . 1 8 0 0 0 0 1
added in added a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 0 0 0 0 1
and then and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 0 0 0 0 1
for an for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 10 0 0 0 0 1
(0.5 mg/ml) (0.5 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (./). 5 9 0 0 0 0 1
Then MTT then T Th The Then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 0 0 0 0 1
crystals were crystals c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 0 0 0 1
formed is formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 8 0 0 0 0 1
absorbance was absorbance a ab abs abso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 9 0 0 0 0 1
and data and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 0 0 0 1
(Dai et (dai ( (D (Da (Dai BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (.,). 5 3 0 0 0 0 1
Morphological observation morphological M Mo Mor Morp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 4 0 0 0 0 1
A549 cells a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 no 0 9 0 0 0 0 1
cell density cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 ./ 2 10 0 0 0 0 1
24 h. 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 2 ..,,. 5 9 0 0 0 0 1
ÂµM concentrations Âµm Âµ ÂµM ÂµM ÂµM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 ., 2 9 0 0 0 0 1
cells were cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 8 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 8 0 0 0 0 1
microscope (Nikon, microscope m mi mic micr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 (,.). 5 9 0 0 0 0 1
Acridine orange acridine A Ac Acr Acri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 (/) 3 8 0 0 0 0 1
A549 cells a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 . 1 9 0 0 0 0 1
cells/ml and cells/ml c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 / 1 8 0 0 0 0 1
compound 4q compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 8 0 0 0 0 1
Then, 100 then, T Th The Then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 , 1 8 0 0 0 0 1
Acridine Orange acridine A Ac Acr Acri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 (.,) 4 8 0 0 0 0 1
Bromide (Vundru bromide B Br Bro Brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 (.,) 4 9 0 0 0 0 1
in equal in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 3 (/)(., 6 10 0 0 0 0 1
2017), then 2017), 2 20 201 2017 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 3 ), 2 9 0 0 0 0 1
fluorescence microscope fluorescence f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 () 2 8 0 0 0 0 1
emission (550 emission e em emi emis BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 (). 3 6 0 0 0 0 1
4â²,6-diamidino-2-phenylindole nucleic 4â²,6-diamidino-2-phenylindole 4 4â² 4â², 4â²,6 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 ,--- 4 9 0 0 0 0 1
(DAPI) (DAPI) (dapi) ( (D (DA (DAP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 () 2 1 0 0 0 0 1
Morphological changes morphological M Mo Mor Morp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 7 0 0 0 0 1
cytotoxic compound cytotoxic c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 no 0 9 0 0 0 0 1
the DAPI the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 9 0 0 0 0 1
small modifications. small s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 4 . 1 9 0 0 0 0 1
for 72 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 , 1 9 0 0 0 0 1
PBS then pbs P PB PBS PBS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 no 0 9 0 0 0 0 1
then permeabilized then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 8 0 0 0 0 1
staining with staining s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 10 0 0 0 0 1
observed under observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 9 0 0 0 0 1
at 359 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 9 0 0 0 0 1
200X magnification 200x 2 20 200 200X BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 (.,). 5 7 0 0 0 0 1
Flow cytometric flow F Fl Flo Flow BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 4 0 0 0 0 1
Measurement of measurement M Me Mea Meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 8 0 0 0 0 1
The cyanine the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 -(,,,--,,,- 11 9 0 0 0 0 1
tetraethylbenzimidazolylcarbocyanine iodide) tetraethylbenzimidazolylcarbocyanine t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 ) 1 8 0 0 0 0 1
a cell-penetrating a a a a a BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 5 - 1 10 0 0 0 0 1
energized and energized e en ene ener BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 , 1 8 0 1 0 0 1
mitochondrial potential mitochondrial m mi mit mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 no 0 9 0 1 0 0 1
from green from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 (.,). 5 9 0 1 0 0 1
was assessed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 (). 3 8 0 1 0 0 1
(1.5x10 6 (1.5x10 ( (1 (1. (1.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (./) 4 9 0 1 0 0 1
allowed to allowed a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 8 0 1 0 0 1
incubated with incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,. 4 8 0 1 0 0 1
concentrations for concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 9 0 1 0 0 1
with PBS with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 -() 3 8 0 1 0 0 1
and incubated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 10 0 1 0 0 1
were washed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 , 1 9 0 1 0 0 1
centrifuged and centrifuged c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 , 1 8 0 1 0 0 1
cytometer (BD cytometer c cy cyt cyto BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 (,). 4 5 0 1 0 0 1
Cell cycle cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 3 0 0 0 0 1
In order in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 7 no 0 8 0 0 0 0 1
mechanistically responsible mechanistically m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 no 0 9 0 0 0 0 1
cells towards cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 9 0 0 0 0 1
performed to performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 9 0 0 0 0 1
in various in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 (.,)., 6 9 0 0 0 0 1
A549 cancer a549 A A5 A54 A549 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 no 0 8 0 0 0 0 1
various concentrations various v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 . 1 8 0 0 0 0 1
h. Untreated h. h h. h. h. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 ., 2 9 0 0 0 0 1
fixed overnight fixed f fi fix fixe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 -. 2 10 0 0 0 0 1
were pelleted were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 9 0 0 0 0 1
propidium iodide propidium p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (/) 3 8 0 0 0 0 1
37 o 37 3 37 37 37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 7 , 1 9 0 0 0 0 1
analyzed on analyzed a an ana anal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (.,). 5 8 0 0 0 0 1
Annexin assay annexin A An Ann Anne BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 8 no 0 2 0 0 0 0 1
A fundamental a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 9 8 no 0 8 0 0 0 0 1
phosphatidyl serine phosphatidyl p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 8 () 2 10 0 0 0 0 1
surface of surface s su sur surf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 9 0 0 0 0 1
of phospholipid of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 8 0 0 0 0 1
condition is condition c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 , 1 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 no 0 9 0 0 0 0 1
cell. Translocation cell. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 9 0 0 0 0 1
of apoptosis of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 (.,). 5 9 0 0 0 0 1
this phenomenon this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 , 1 9 0 0 0 0 1
12-well plate 12-well 1 12 12- 12-w BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 - 1 9 0 0 0 0 1
of compound of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 8 0 0 0 0 1
and treated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 no 0 8 0 0 0 0 1
processed with processed p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 -() 3 9 0 0 0 0 1
staining (Bio staining s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 (),' 4 9 0 0 0 0 1
instructions. Further, instructions. i in ins inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 .,/ 3 9 0 0 0 0 1
parameters were parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 no 0 8 0 0 0 0 1
propidium iodide-negative propidium p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 8 -, 2 9 0 0 0 0 1
and propidium and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 -,. 3 8 0 0 0 0 1
Clonogenic growth clonogenic C Cl Clo Clon BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 no 0 6 0 0 0 0 1
Lung cancer lung L Lu Lun Lung BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 8 0 0 0 0 1
seeded into seeded s se see seed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 - 1 10 0 0 0 0 1
treated with treated t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 . 1 9 0 0 0 0 1
was replaced was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 . 1 8 0 0 0 0 1
incubation, the incubation, i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 , 1 9 0 0 0 0 1
with 1 with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 . 1 9 0 0 0 0 1
of stained of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 9 0 0 0 0 1
system (Vilber system s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 (,). 4 9 0 0 0 0 1
calculated as calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 9 0 0 0 0 1
(Moghaddam et (moghaddam ( (M (Mo (Mog BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 (.,). 5 4 0 0 0 0 1
Raju Bathula raju R Ra Raj Raju BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 1 1 0 0
Asian Pacific asian A As Asi Asia BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 10 0 0 1 0 0
420 420 420 4 42 420 420 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 0 0 0 0
Molecular Docking molecular M Mo Mol Mole BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 4 0 1 0 0 1
In this in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 no 0 8 0 1 0 0 1
examine the examine e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 10 0 1 0 0 1
Dock Methodology dock D Do Doc Dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 1 0 0 1
The docking the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 1 0 0 1
such as such s su suc such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
binding cavity binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,, 2 9 0 1 0 0 1
and finally and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 10 0 1 0 0 1
of a-amylase of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -( 2 9 0 1 0 0 1
ID: 1M17) id: I ID ID: ID: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 :)- 3 9 0 1 0 0 1
molecules are molecules m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
minimized using minimized m mi min mini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
using builder using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 1 0 0 1
using MMFF94x using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 1 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
Placement, Rescoring placement, P Pl Pla Plac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
finally optimized finally f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 / 1 8 0 1 0 0 1
DG score. dg D DG DG DG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
best interactions best b be bes best BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
interactions (El-Azab interactions i in int inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (-.,). 6 6 0 1 0 0 1
ADME Predictions adme A AD ADM ADME BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 no 0 2 0 0 0 0 1
The in the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 8 0 0 0 0 1
compounds were compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 9 0 0 0 0 1
preADMET (http://preadmet.bmdrc.org/). preadmet p pr pre preA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 1 (://../). 9 8 0 0 0 0 1
properties, human properties, p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 ,(),- 5 9 0 0 0 0 1
cell permeability, cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 ,() 3 8 0 0 0 0 1
cell permeability, cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 , 1 10 0 0 0 0 1
barrier penetration barrier b ba bar barr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 () 2 8 0 0 0 0 1
program. program. program. p pr pro prog BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 . 1 1 0 0 0 0 1
Acknowledgments Acknowledgments acknowledgments A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 10 0 0 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 9 0 0 0 0 1
Science and science S Sc Sci Scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 9 0 0 0 0 1
the laboratory the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 10 0 0 0 0 1
Delhi for delhi D De Del Delh BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 . 1 10 0 0 0 0 1
Conflict of conflict C Co Con Conf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 4 0 0 0 0 1
The authors the T Th The The BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 . 1 10 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 no 0 10 0 0 0 0 1
Boussari O, boussari B Bo Bou Bous BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ,,,(). 6 10 0 0 0 0 1
to estimate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 --. 3 9 0 0 0 0 1
Epidemiol, 53, epidemiol, E Ep Epi Epid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ,,-. 4 3 0 0 0 0 1
Bustamante J, bustamante B Bu Bus Bust BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 3 ,,,(). 6 9 0 0 0 0 1
mitochondrial membrane mitochondrial m mi mit mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 no 0 9 0 0 0 0 1
by PSC by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 - 1 8 0 0 0 0 1
leukemia. Toxicol leukemia. l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 .,,-. 5 7 0 0 0 0 1
Chakraborty S, chakraborty C Ch Cha Chak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 3 ,(). 4 9 0 0 0 0 1
treatment. Ecancermedicalscience, treatment. t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 .,,. 4 6 0 0 0 0 1
Dai Y, dai D Da Dai Dai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 3 ,,,(). 6 9 0 0 0 0 1
inhibition of inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 no 0 9 0 0 0 0 1
extract in extract e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 no 0 9 0 0 0 0 1
EGFR expression. egfr E EG EGF EGFR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 .,,-. 5 6 0 0 0 0 1
El-Azab AS, el-azab E El El- El-A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 -,-,--,(). 10 8 0 0 0 0 1
Synthesis, anticancer synthesis, S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 ,- 2 9 0 0 0 0 1
quinazoline-isatin conjugates: quinazoline-isatin q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 -: 2 8 0 0 0 0 1
receptor-tyrosine kinase receptor-tyrosine r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 - 1 8 0 0 0 0 1
studies. J studies. s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 .,,-. 5 7 0 0 0 0 1
Fiedler W, fiedler F Fi Fie Fied BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ,,,().-, 8 9 0 0 0 0 1
Phase I phase P Ph Pha Phas BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 () 2 8 0 0 0 0 1
acute myeloid acute a ac acu acut BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-. 5 7 0 1 0 0 1
GÃ¡lvez J, gÃ¡lvez G GÃ¡ GÃ¡l GÃ¡lv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,()., 7 8 0 1 0 0 1
synthesis, and synthesis, s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,-[,-] 6 9 0 1 0 0 1
quinazolines as quinazolines q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 : 1 8 0 1 0 0 1
and MM/GBSA and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 /.,,-. 6 7 0 1 0 0 1
Gupta T, gupta G Gu Gup Gupt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 5 ,,,(). 6 9 0 1 0 0 1
on quinazolines on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 :. 2 8 0 1 0 0 1
Synth Commun, synth S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,-. 4 4 0 1 0 0 1
Helal M, helal H He Hel Hela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,-,,()., 8 8 0 1 0 0 1
biological evaluation biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
of pyridine of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,- 2 8 0 1 0 0 1
analgesic agents. analgesic a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ., 2 8 0 1 0 0 1
135, 764-73. 135, 1 13 135 135, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,-. 3 1 0 1 0 0 1
Helfrich BA, helfrich H He Hel Helf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,().(), 9 9 0 1 0 0 1
a small a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 5 , 1 8 0 1 0 0 1
SCLC cell sclc S SC SCL SCLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,, 3 8 0 1 0 0 1
2314-22. 2314-22. 2314-22. 2 23 231 2314 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 -. 2 1 0 1 0 0 1
Jabir NR, jabir J Ja Jab Jabi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
Azoles containing azoles A Az Azo Azol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
and treatment: and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 :., 3 8 0 1 0 0 1
18, 6-14. 18, 1 18 18, 18, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,-. 3 1 0 1 0 0 1
Kumar NP, kumar K Ku Kum Kuma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
acid promoted acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 7 0 1 0 0 1
fused-dihydrodibenzo-quinolinones: Anticancer fused-dihydrodibenzo-quinolinones: f fu fus fuse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 --:, 4 8 0 1 0 0 1
tubulin polymerization tubulin t tu tub tubu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
studies. Bioorg studies. s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-. 5 6 0 1 0 0 1
Kumar NR, kumar K Ku Kum Kuma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
of Novel of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 [,:,][,-] 9 8 0 1 0 0 1
Derivatives, their derivatives, D De Der Deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 , 1 8 0 1 0 0 1
modelling studies. modelling m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-. 5 7 0 1 0 0 1
Kummar S, kummar K Ku Kum Kumm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,(). 4 8 0 1 0 0 1
trials for trials t tr tri tria BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.- 3 7 0 1 0 0 1
Kurumurthy C, kurumurthy K Ku Kur Kuru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
of novel of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,-[,-] 7 8 0 1 0 0 1
derivatives and derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 . 1 8 0 1 0 0 1
Lett, 24, lett, L Le Let Lett BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,-. 4 2 0 1 0 0 1
Mani GS, mani M Ma Man Mani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,().- 7 10 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 [,-]- 5 7 0 1 0 0 1
functionalization of functionalization f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
activity. Org activity. a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-. 5 5 0 1 0 0 1
Mikhalev AI, mikhalev M Mi Mik Mikh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,',,(). 7 7 0 1 0 0 1
Synthesis, anti-inflammatory synthesis, S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,- 2 8 0 1 0 0 1
pyrido[2,1-b]quinazoline derivatives. pyrido[2,1-b]quinazoline p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 [,-].,, 7 8 0 1 0 0 1
124-6. 124-6. 124-6. 1 12 124 124- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -. 2 1 0 1 0 0 1
Moghaddam S, moghaddam M Mo Mog Mogh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
Curcumin inhibits curcumin C Cu Cur Curc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 - 1 8 0 1 0 0 1
cancer progression cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-. 5 8 0 1 0 0 1
Motyckova G, motyckova M Mo Mot Moty BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,(). 4 8 0 1 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .' 2 9 0 1 0 0 1
Myeloid Leukemia', myeloid M My Mye Myel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ',,- 4 6 0 1 0 0 1
Moussa G, moussa M Mo Mou Mous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
click modifiable click c cl cli clic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 5 - 1 8 0 1 0 0 1
agents: Design, agents: a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 :,, 3 8 0 1 0 0 1
study. Eur study. s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-. 5 5 0 1 0 0 1
Nagender P, nagender N Na Nag Nage BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,()., 7 8 0 1 0 0 1
cytotoxicity, antimicrobial cytotoxicity, c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,- 2 9 0 1 0 0 1
pyrazolo [3, pyrazolo p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 [,-], 5 8 0 1 0 0 1
2, 3-triazole 2, 2 2, 2, 2, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,-.,,-. 7 8 0 1 0 0 1
Nekkanti S, nekkanti N Ne Nek Nekk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 9 0 1 0 0 1
of 1, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,----- 7 8 0 1 0 0 1
via 1, via v vi via via BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,-: 3 7 0 1 0 0 1
Evaluation and evaluation E Ev Eva Eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 -.,, 4 8 0 1 0 0 1
7210-21. 7210-21. 7210-21. 7 72 721 7210 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -. 2 1 0 1 0 0 1
Oluwaseye A, oluwaseye O Ol Olu Oluw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
studies on studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -()- 4 8 0 1 0 0 1
anticonvulsant activities. anticonvulsant a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,-. 5 8 0 1 0 0 1
Pordeli M, pordeli P Po Por Pord BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,(). 6 8 0 1 0 0 1
Asian Pacific asian A As Asi Asia BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 , 1 10 1 1 1 0 0
DOI:10.31557/APJCP.2020.21.2.411 DOI:10.31557/APJCP.2020.21.2.411 doi:10.31557/apjcp.2020.21.2.411 D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 :./.... 7 5 0 0 0 0 0
Design, One design, D De Des Desi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 , 1 10 0 0 0 0 0
effects of effects e ef eff effe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 []-- 4 8 1 1 0 0 1
derivatives on derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ., 2 9 1 1 0 0 1
24, 299-311. 24, 2 24 24, 24, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-. 3 1 1 1 0 0 1
Riyasdeen A, riyasdeen R Ri Riy Riya BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,(). 6 8 1 1 0 0 1
Antiproliferative and antiproliferative A An Ant Anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 - 1 8 1 1 0 0 1
metallosurfactant in metallosurfactant m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -. 2 8 1 1 0 0 1
Advances, 4, advances, A Ad Adv Adva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,,-. 4 3 1 1 0 0 1
Sagir H, sagir S Sa Sag Sagi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,().-/: 9 8 1 1 0 0 1
an efficient an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 no 0 8 1 1 0 0 1
of substituted of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -[,-] 5 8 1 1 0 0 1
admicellar medium. admicellar a ad adm admi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,-. 5 6 1 1 0 0 1
Samiksha M, samiksha S Sa Sam Sami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,(). 4 8 1 1 0 0 1
medicinal aspects medicinal m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 7 1 1 0 0 1
derivatives. Int derivatives. d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .,,-. 5 5 1 1 0 0 1
Sgorbati S, sgorbati S Sg Sgo Sgor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,(). 6 9 1 1 0 0 1
cytometry of cytometry c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,---()- 7 8 1 1 0 0 1
suspensions of suspensions s su sus susp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 no 0 8 1 1 0 0 1
of plants. of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .,,-. 5 5 1 1 0 0 1
Shagufta, Ahmad shagufta, S Sh Sha Shag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,(). 4 8 1 1 0 0 1
potential of potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 8 1 1 0 0 1
Med Chem med M Me Med Med BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,-. 4 3 1 1 0 0 1
Taylor AP, taylor T Ta Tay Tayl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 ,,,(). 6 8 1 1 0 0 1
advances in advances a ad adv adva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 8 1 1 0 0 1
Biomol Chem, biomol B Bi Bio Biom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,-. 4 3 1 1 0 0 1
Thun MJ, thun T Th Thu Thun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,(). 6 8 1 1 0 0 1
burden of burden b bu bur burd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 :., 3 9 1 1 0 0 1
31, 100-10. 31, 3 31 31, 31, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-. 3 1 1 1 0 0 1
Tilley JW, tilley T Ti Til Till BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 ,,,().-() 9 10 1 1 0 0 1
pyrido[2,1-b]quinazoline-8-carboxamides as pyrido[2,1-b]quinazoline-8-carboxamides p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 [,-]-- 6 8 1 1 0 0 1
antiallergy agents. antiallergy a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,-. 5 6 1 1 0 0 1
Vundru SS, vundru V Vu Vun Vund BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,().- 6 9 1 1 0 0 1
arrest and arrest a ar arr arre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 1 0 0 1
potential in potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 --. 3 7 1 1 0 0 1
Complem Altern complem C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,. 3 4 1 1 0 0 1
Ward TH, ward W Wa War Ward BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 0 ,,,(). 6 8 1 1 0 0 1
apoptosis. Br apoptosis. a ap apo apop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,. 4 4 1 1 0 0 1
Yang K, yang Y Ya Yan Yang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 ,,,(). 6 8 1 1 0 0 1
Substituted 4H-Pyrido[1,2-a]pyrimidines substituted S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 -[,-]- 6 8 1 1 0 0 1
three-component condensation three-component t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -., 3 7 1 1 0 0 1
15, 519-24. 15, 1 15 15, 15, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-. 3 1 1 1 0 0 1
Zaki YH, zaki Z Za Zak Zaki BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,-,(). 6 8 1 1 0 0 1
synthesis, and synthesis, s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 , 1 8 1 1 0 0 1
some pyridines, some s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ,,,,, 5 8 1 1 0 0 1
Î²-naphthyl carbamate, Î²-naphthyl Î² Î²- Î²-n Î²-na BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -,[,-] 6 7 1 1 0 0 1
derivatives. Chem derivatives. d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .,,. 4 5 1 1 0 0 1
Zhao B, zhao Z Zh Zha Zhao BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 ,,,(). 6 9 1 1 0 0 1
H-pyrazolo [3, h-pyrazolo H H- H-p H-py BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -[,-] 5 8 1 1 0 0 1
selective FGFR selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .,, 3 8 1 1 0 0 1
629-34. 629-34. 629-34. 6 62 629 629- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -. 2 1 1 1 0 0 1
Zhu YY, zhu Z Zh Zhu Zhu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,(). 5 8 1 1 0 0 1
activities of activities a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 1 1 0 0 1
arrest and arrest a ar arr arre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 1 0 0 1
in HepG2 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 . 1 8 1 1 0 0 1
Rep, 12, rep, R Re Rep Rep, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,,-. 4 2 1 1 0 0 1
Å»uryÅ A, Å¼uryÅ Å» Å»u Å»ur Å»ury BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,-,(). 7 8 1 1 0 0 1
effect of effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 , 1 8 1 1 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 8 1 1 0 0 1
lung cancer lung l lu lun lung BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .,,-. 5 7 1 1 0 0 1
This work this T Th Thi This BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 - 1 10 1 1 0 0 1
Non Commercial non N No Non Non BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 .. 2 7 1 1 0 0 1

